
Stock Earnings
Evercore ISI upgrades CRISPR Therapeutics AG (CRSP) stock to an Outperform
CRISPR Therapeutics AG’s recently made public that its Chief Medical Officer Patel Naimish unloaded Company’s shares for reported $0.14 million
CRISPR Therapeutics AG’s recently made public that its Chief Medical Officer Patel Naimish unloaded Company’s shares for reported $0.14 million
In a filing, CRISPR Therapeutics AG revealed its Chief Medical Officer Patel Naimish unloaded Company’s shares for reported $0.14 million
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
CRISPR Therapeutics AG’s recently made public that its Chief Medical Officer Patel Naimish unloaded Company’s shares for reported $0.14 million
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or